(Q33387430)

English

Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

liver transplantation

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Markus Büchler

10

object named as

M W Büchler

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

K Hoffmann

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

H Glimm

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

B Radeleff

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

G Richter

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

C Heining

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

I Schenkel

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A Zahlten-Hinguranage

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

P Schirrmacher

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

J Schmidt

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

D Jaeger

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

C von Kalle

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

P Schemmer

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

26 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

349

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-8-349

0 references

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630329

21 June 2018

Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630329

21 June 2018

Liver transplantation for hepatocellular carcinoma: is there evidence for expanding the selection criteria?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630329

21 June 2018

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630329

21 June 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630329

21 June 2018

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630329

21 June 2018

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630329

21 June 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630329

21 June 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630329

21 June 2018

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630329

21 June 2018

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630329

21 June 2018

A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-349

21 January 2018

The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-349

21 January 2018

Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-349

21 January 2018

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/19036146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19036146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19036146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/19036146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

https://pubmed.ncbi.nlm.nih.gov/19036146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does Additional Doxorubicin Chemotherapy Improve Outcome in Patients with Hepatocellular Carcinoma Treated by Liver Transplantation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19036146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-8-349

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33387430&oldid=1615397756"